Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 4.24B | 4.38B | 4.73B | 5.15B | 5.07B | 4.28B |
Gross Profit | 743.60M | 749.10M | 853.80M | 976.80M | 1.04B | 894.50M |
EBITDA | 388.90M | -288.60M | 93.20M | 663.80M | 778.10M | 590.70M |
Net Income | 142.20M | -511.50M | -136.80M | 309.80M | 402.40M | 253.00M |
Balance Sheet | ||||||
Total Assets | 3.70B | 3.66B | 4.63B | 5.19B | 5.31B | 4.75B |
Cash, Cash Equivalents and Short-Term Investments | 368.80M | 350.20M | 365.50M | 316.50M | 361.70M | 348.90M |
Total Debt | 1.84B | 2.05B | 2.20B | 2.29B | 2.29B | 2.06B |
Total Liabilities | 0.00 | 2.97B | 3.30B | 3.54B | 3.66B | 3.36B |
Stockholders Equity | 855.80M | 689.40M | 1.33B | 1.64B | 1.65B | 1.39B |
Cash Flow | ||||||
Free Cash Flow | 171.10M | 224.10M | 383.40M | 341.10M | 164.70M | 536.40M |
Operating Cash Flow | 224.60M | 305.70M | 497.20M | 441.40M | 271.30M | 602.60M |
Investing Cash Flow | -24.10M | -36.60M | -91.30M | -181.20M | -226.20M | -49.00M |
Financing Cash Flow | -92.90M | -270.00M | -358.80M | -286.20M | -32.80M | -461.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $1.44B | 15.22 | 18.63% | 0.16% | 6.26% | 44.74% | |
74 Outperform | $726.28M | 14.19 | 10.69% | 6.86% | -4.89% | ― | |
70 Outperform | $1.46B | 15.06 | 9.84% | 2.43% | 3.04% | -16.49% | |
63 Neutral | £1.75B | 11.25 | 2.35% | 3.21% | 0.29% | -37.72% | |
63 Neutral | $1.40B | 14.21 | 8.02% | ― | 1.30% | -44.70% | |
56 Neutral | $1.23B | 45.68 | -2.77% | 4.12% | 1.14% | -149.26% | |
51 Neutral | $1.09B | 7.88 | 18.67% | 2.48% | -6.16% | ― |
Leggett & Platt reported a 6% decrease in second-quarter sales for 2025 compared to the same period in 2024, with sales totaling $1.1 billion. Despite the decline, the company improved its profitability, with EPS rising to $0.38 and adjusted EPS to $0.30, a slight increase from the previous year. The company reduced its debt by $143 million, strengthening its balance sheet, and amended its credit facility to extend maturity to 2030. Leggett & Platt remains on track to sell its Aerospace business and maintains its full-year sales and adjusted EPS guidance, despite macroeconomic challenges.
The most recent analyst rating on (LEG) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Leggett & Platt stock, see the LEG Stock Forecast page.
On July 24, 2025, Leggett & Platt, Incorporated amended its credit agreement with JPMorgan Chase Bank and other lenders, resulting in several key changes. These include a reduction in the revolving credit facility from $1.2 billion to $1.0 billion, an extension of the maturity date to July 24, 2030, and adjustments to borrowing terms such as the reinstatement of borrowing in Canadian dollars and the suspension of borrowing in Mexican Pesos. The company’s commercial paper program was also reduced from $1.2 billion to $1.0 billion, reflecting a strategic adjustment in its financial operations.
The most recent analyst rating on (LEG) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Leggett & Platt stock, see the LEG Stock Forecast page.
Leggett & Platt has amended and restated its Flexible Stock Plan, which was approved by shareholders during the Annual Meeting on May 7, 2025. The plan aims to attract and retain key personnel by offering stock-based benefits and aligns participants’ interests with those of shareholders. Key amendments include increasing available shares by 5 million, extending the plan’s term to 2035, and introducing provisions for dividend credits and clawback rights. Additionally, the meeting saw the election of eight directors, ratification of PricewaterhouseCoopers LLP as the independent auditor, and approval of executive compensation.